GENFIT (GNFT.PA) Fundamental Analysis & Valuation

EPA:GNFT • FR0004163111

Current stock price

8.68 EUR
+0.7 (+8.77%)
Last:

This GNFT.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. GNFT.PA Profitability Analysis

1.1 Basic Checks

  • In the past year GNFT has reported negative net income.
  • In the past year GNFT has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: GNFT reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: GNFT reported negative operating cash flow in multiple years.
GNFT.PA Yearly Net Income VS EBIT VS OCF VS FCFGNFT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

  • With a decent Return On Assets value of -17.98%, GNFT is doing good in the industry, outperforming 60.76% of the companies in the same industry.
  • GNFT has a Return On Equity (-74.24%) which is in line with its industry peers.
Industry RankSector Rank
ROA -17.98%
ROE -74.24%
ROIC N/A
ROA(3y)-8.88%
ROA(5y)-10.74%
ROE(3y)-21.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GNFT.PA Yearly ROA, ROE, ROICGNFT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600

1.3 Margins

  • GNFT's Profit Margin has declined in the last couple of years.
  • In the last couple of years the Operating Margin of GNFT has declined.
  • GNFT has a better Gross Margin (95.42%) than 88.61% of its industry peers.
  • GNFT's Gross Margin has been stable in the last couple of years.
  • GNFT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 95.42%
OM growth 3Y-50.59%
OM growth 5YN/A
PM growth 3Y-69.99%
PM growth 5YN/A
GM growth 3Y-0.4%
GM growth 5Y0.52%
GNFT.PA Yearly Profit, Operating, Gross MarginsGNFT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. GNFT.PA Health Analysis

2.1 Basic Checks

  • GNFT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, GNFT has more shares outstanding
  • The number of shares outstanding for GNFT has been increased compared to 5 years ago.
  • The debt/assets ratio for GNFT is higher compared to a year ago.
GNFT.PA Yearly Shares OutstandingGNFT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
GNFT.PA Yearly Total Debt VS Total AssetsGNFT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • GNFT has an Altman-Z score of -0.71. This is a bad value and indicates that GNFT is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of GNFT (-0.71) is worse than 60.76% of its industry peers.
  • A Debt/Equity ratio of 0.10 indicates that GNFT is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.10, GNFT is doing good in the industry, outperforming 63.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z -0.71
ROIC/WACCN/A
WACC7.52%
GNFT.PA Yearly LT Debt VS Equity VS FCFGNFT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

  • GNFT has a Current Ratio of 3.74. This indicates that GNFT is financially healthy and has no problem in meeting its short term obligations.
  • GNFT has a Current ratio of 3.74. This is in the better half of the industry: GNFT outperforms 72.15% of its industry peers.
  • GNFT has a Quick Ratio of 3.74. This indicates that GNFT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 3.74, GNFT is in the better half of the industry, outperforming 77.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.74
Quick Ratio 3.74
GNFT.PA Yearly Current Assets VS Current LiabilitesGNFT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. GNFT.PA Growth Analysis

3.1 Past

  • GNFT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -289.19%.
  • The earnings per share for GNFT have been decreasing by -70.77% on average. This is quite bad
  • The Revenue for GNFT has decreased by -45.94% in the past year. This is quite bad
  • GNFT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.61% yearly.
EPS 1Y (TTM)-289.19%
EPS 3Y-70.77%
EPS 5YN/A
EPS Q2Q%-137.74%
Revenue 1Y (TTM)-45.94%
Revenue growth 3Y-6.06%
Revenue growth 5Y11.61%
Sales Q2Q%-43.21%

3.2 Future

  • The Earnings Per Share is expected to decrease by -29.44% on average over the next years. This is quite bad
  • The Revenue is expected to decrease by -2.23% on average over the next years.
EPS Next Y-213.72%
EPS Next 2Y-83.29%
EPS Next 3Y-41.45%
EPS Next 5Y-29.44%
Revenue Next Year-14.39%
Revenue Next 2Y-3.46%
Revenue Next 3Y7.33%
Revenue Next 5Y-2.23%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GNFT.PA Yearly Revenue VS EstimatesGNFT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M
GNFT.PA Yearly EPS VS EstimatesGNFT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

1

4. GNFT.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GNFT. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 850.98, the valuation of GNFT can be described as expensive.
  • GNFT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. GNFT is cheaper than 72.15% of the companies in the same industry.
  • GNFT is valuated expensively when we compare the Price/Forward Earnings ratio to 23.54, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 850.98
GNFT.PA Price Earnings VS Forward Price EarningsGNFT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600 800

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GNFT.PA Per share dataGNFT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

  • A cheap valuation may be justified as GNFT's earnings are expected to decrease with -41.45% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-83.29%
EPS Next 3Y-41.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GNFT.PA Dividend Analysis

5.1 Amount

  • GNFT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GNFT.PA Fundamentals: All Metrics, Ratios and Statistics

GENFIT

EPA:GNFT (4/10/2026, 7:00:00 PM)

8.68

+0.7 (+8.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)04-02
Earnings (Next)05-21
Inst Owners11.39%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap434.35M
Revenue(TTM)45.41M
Net Income(TTM)-38.96M
Analysts90
Price Target12.53 (44.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)12.04%
PT rev (3m)42.46%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-22.74%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)19.74%
Revenue NY rev (3m)30.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 850.98
P/S 9.57
P/FCF N/A
P/OCF N/A
P/B 8.28
P/tB 204.3
EV/EBITDA N/A
EPS(TTM)-0.7
EYN/A
EPS(NY)0.01
Fwd EY0.12%
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.91
BVpS1.05
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -17.98%
ROE -74.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 95.42%
FCFM N/A
ROA(3y)-8.88%
ROA(5y)-10.74%
ROE(3y)-21.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-50.59%
OM growth 5YN/A
PM growth 3Y-69.99%
PM growth 5YN/A
GM growth 3Y-0.4%
GM growth 5Y0.52%
F-Score2
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 188.34%
Cap/Sales 7.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.74
Quick Ratio 3.74
Altman-Z -0.71
F-Score2
WACC7.52%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-289.19%
EPS 3Y-70.77%
EPS 5YN/A
EPS Q2Q%-137.74%
EPS Next Y-213.72%
EPS Next 2Y-83.29%
EPS Next 3Y-41.45%
EPS Next 5Y-29.44%
Revenue 1Y (TTM)-45.94%
Revenue growth 3Y-6.06%
Revenue growth 5Y11.61%
Sales Q2Q%-43.21%
Revenue Next Year-14.39%
Revenue Next 2Y-3.46%
Revenue Next 3Y7.33%
Revenue Next 5Y-2.23%
EBIT growth 1Y-217.08%
EBIT growth 3Y-53.58%
EBIT growth 5YN/A
EBIT Next Year13.75%
EBIT Next 3Y23.32%
EBIT Next 5YN/A
FCF growth 1Y87.75%
FCF growth 3Y-47.27%
FCF growth 5YN/A
OCF growth 1Y93.86%
OCF growth 3Y-46.21%
OCF growth 5YN/A

GENFIT / GNFT.PA Fundamental Analysis FAQ

What is the fundamental rating for GNFT stock?

ChartMill assigns a fundamental rating of 2 / 10 to GNFT.PA.


What is the valuation status for GNFT stock?

ChartMill assigns a valuation rating of 1 / 10 to GENFIT (GNFT.PA). This can be considered as Overvalued.


What is the profitability of GNFT stock?

GENFIT (GNFT.PA) has a profitability rating of 2 / 10.